The prediction of risk of recurrence and time to recurrence of hepatocellular carcinoma after orthotopic liver transplantation: A pilot study
J W Marsh, I Dvorchik, M Subotin, V Balan, J Rakela, E P Popechitelev, V Subbotin, A Casavilla, B I Carr, J J Fung, S Iwatsuki – 30 December 2003 – Orthotopic liver transplantation (OLTx) in the presence of hepatocellular carcinoma (HCC) has been complicated by high recurrence rates. The ability to determine the risk and timing of HCC recurrence on an individual basis would greatly aid in the candidate selection process resulting in a more efficient use of donated organs and allow the individualization and better evaluation of adjuvant chemotherapy.